Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats

Neurochemistry International
B KläsnerNikolaus Plesnila

Abstract

Following cerebral ischemia bradykinin/kinin B(2) receptors mediate inflammatory responses resulting in edema formation and secondary brain damage. However, the therapeutic window for B(2) receptor inhibition determining its potential clinical use has not been investigated so far. The aim of the current study was therefore to investigate the effect of delayed B(2) receptor inhibition on morphological and functional outcome following experimental stroke. Rats were subjected to 90 min of middle cerebral artery occlusion (MCAo) by an intraluminal filament. Animals received 0.9% NaCl or 1.0mg/kg/day Anatibant (LF 16-0687 Ms), a selective bradykinin B(2) receptor antagonist, for 3 days beginning at different time points after MCAo: 1, 2.5, 4.5, or 6.5h (n=10 per group). Neurological recovery was examined daily, infarct volume on day 7 after MCAo. Animal physiology was not influenced by B(2) receptor inhibition. Significant improvement of functional outcome was observed when treatment was delayed up to 4.5h after ischemia (p<0.05 versus vehicle). Inhibition of B(2) receptors during ischemia, i.e. when the inhibitor was given 1h after MCAo, reduced infarct volume in the basal ganglia and in the cortex by 49% (p<0.05) and 26% (p<0.05),...Continue Reading

References

Mar 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·F M CorrêaS H Snyder
Jul 1, 1992·Journal of Neuropathology and Experimental Neurology·J H Garcia
Oct 1, 1991·Journal of Neurochemistry·A J CholewinskiG P Wilkin
Jun 1, 1985·Journal of Neurochemistry·K KariyaT Sasaki
Jun 1, 1981·Journal of Neurochemistry·K KariyaH Okamoto
Dec 1, 1984·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A UnterbergA Baethmann
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·A G ScicliO A Carretero
Aug 31, 1982·Biochemical and Biophysical Research Communications·K KariyaY Okada
Jun 1, 1983·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M WahlF Wagner
Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Apr 1, 1993·Stroke; a Journal of Cerebral Circulation·T KamiyaA Terashi
Jun 30, 1994·Nature·V ParpuraP G Haydon
May 1, 1996·Brain Injury : [BI]·T Yong, D S Linthicum
Jun 1, 1996·Immunopharmacology·D M RaidooK D Bhoola
Oct 24, 1998·British Journal of Pharmacology·D PruneauJ L Paquet
Jan 15, 2000·Advances in Experimental Medicine and Biology·L Schilling, M Wahl
Oct 24, 2000·The Journal of Comparative Neurology·E Y ChenJ H Kordower
Nov 1, 2001·Journal of Neurotrauma·N PlesnilaA Baethmann
Nov 8, 2001·European Journal of Pharmacology·R CoutureF Cloutier
Jan 29, 2003·Life Sciences·Mami NodaKeiji Wada
Oct 28, 2003·Journal of Neurotrauma·F HellalC Marchand-Verrecchia
Jul 13, 2004·Current Opinion in Neurology·Julio A ChalelaSteven Warach
Apr 9, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Moritz GrögerNikolaus Plesnila

❮ Previous
Next ❯

Citations

Oct 17, 2006·Expert Opinion on Investigational Drugs·Ibolja Cernak
Jan 1, 2013·Progress in Neurobiology·Christiane Albert-WeißenbergerChristoph Kleinschnitz
May 5, 2012·Neurochemistry International·Ibeth Guevara-Lora
Aug 23, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Peng LvLan Sha
Jun 30, 2011·Free Radical Biology & Medicine·Paul A Fraser
Oct 17, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Weirong FangLishun Mao
Apr 8, 2014·Epilepsia·Priscila Santos Rodrigues SimõesMaria da Graça Naffah Mazzacoratti
Jul 29, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Elisa CuccioneFabien Chauveau
Feb 25, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Zhi-bin ChenYun Xu
Apr 4, 2015·Cell Transplantation·Priscilla D NegraesHenning Ulrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.